FIELD: organic chemistry, pharmaceuticals.
SUBSTANCE: invention relates to compounds of general formula I and pharmaceutically acceptable salt thereof, wherein R1, R3, R4, R5, and R10 are independently H, halogen, C1-C4-alkyl, etc.; R2 is H, halogen, NO2, etc.; R6 is H, C1-C6-alkyl, C1-C6-alkoxy-substituted C1-C4-alkyl, etc.; R7 is H, C1-C4-alkyl or C2-C4-alkenyl, optionally substituted with halogen; R8 and R9 are H, R11 and R12; meanings of the rest substituents are as define in specification.
EFFECT: new compounds with value biological properties and useful as drug having activity in relates to progesterone receptor.
15 cl, 3 tbl, 80 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
AMINOSUBSTITUTED DIARYL [a, d] CYCLOHEPTANE ANALOGUES AS MUSCARINIC AGONISTS AND METHOD OF TREATING PSYCHONEUROLOGICAL DISORDERS | 2004 |
|
RU2394030C2 |
GLUCOCORTICOID RECEPTOR NON-STEROID MODULATORS | 2006 |
|
RU2409577C2 |
TRICYCLIC DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND METHOD OF INHIBITION OF VASOPRESSINE | 1994 |
|
RU2149160C1 |
2, 5, 6, 7-TETRAHYDRO-[1, 4]OXAZEPIN-3-YLAMINES OR 2, 3, 6, 7-TETRAHYDRO-[1, 4]OXAZEPIN-5-YLAMINES | 2011 |
|
RU2570796C2 |
INHIBITOR CONTAINING A TRICYCLIC DERIVATIVE, A METHOD OF ITS PRODUCTION AND ITS USE | 2019 |
|
RU2800543C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
INFLUENZA VIRUS REPLICATION INHIBITORS, METHODS OF APPLICATION AND USING | 2016 |
|
RU2737190C2 |
DERIVATIVES OF DIBENZ[B,F][1,4]OXAZEPINE-11-ON AND THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS, PHARMACEUTICAL COMPOSITION AND METHOD FOR DECREASING OF MULTIMEDICINAL RESISTANCE OF TUMOR CELLS AGAINST CYTOTOXIC DRUG | 1992 |
|
RU2086545C1 |
(PYRIDO/THIENO)[f]OXAZEPINE-5-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED ON THE SAME AND METHOD FOR TREATMENT OF NEUROLOGICAL DISEASES OR MENTAL DISORDERS | 2002 |
|
RU2286347C2 |
Authors
Dates
2007-10-27—Published
2003-04-01—Filed